Microbiome: bacterial imbalance in Crohn's disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

1. Efficacy ofJGH open : an open access journal of gastroenterology and hepatology · 2025
   Article
2. Research advances in nanomaterials with aromatic functional groups for the treatment of inflammatory bowel disease.Frontiers in bioengineering and biotechnology · 2025
   Review
3. Gut microbiota analysis for prediction of clinical relapse in Crohn's disease.Scientific reports · 2022
   Observational
4. Evaluation of changes in intestinal microbiota in Crohn's disease patients after anti-TNF alpha treatment.Scientific reports · 2021
   Article
5. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.Gut microbes · 2020
   Review
6. Oral Probiotics Alleviate Intestinal Dysbacteriosis for People Receiving Bowel Preparation.Frontiers in medicine · 2020
   Article
7. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.BioMed research international · 2019
   Review
8. Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics.Inflammatory bowel diseases · 2018
   Article
9. Genome-resolved metaproteomic characterization of preterm infant gut microbiota development reveals species-specific metabolic shifts and variabilities during early life.Microbiome · 2017
   Article
10. Gut microbiota, epigenetic modification and colorectal cancer.Iranian journal of microbiology · 2017
    Review
11. Autoimmunity and the microbiome: T-cell receptor mimicry of "self" and microbial antigens mediates self tolerance in holobionts: The concepts of "holoimmunity" (TcR-mediated tolerance for the holobiont) and "holoautoimmunity" (loss of tolerance for the holobiont) are introduced.BioEssays : news and reviews in molecular, cellular and developmental biology · 2016
    Article
12. Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi children.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article

Corrections and comments

• Comment on
  The treatment-naive microbiome in new-onset Crohn's disease.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as